clinical trial pre-screening

ki:elements GmbH is a Saarbrücken, Germany-based company founded in 2017 as a spin-off of the German Research Center for Artificial Intelligence (DFKI). It creates AI-driven speech-based digital biomarkers for clinical trials across neurodegenerative and neuropsychiatric indications, partnering with pharma sponsors and research institutions. Its Speech-based Biomarker for Cognition (SB-C) captures memory, processing speed, and executive function through standardized spoken tasks.

Read more

AI-driven speech biomarker analysislongitudinal trackingremote cognitive assessment via telephone, smartphone app, or web browser